Navigation Links
Curemark CEO Presents Autism Findings at Prestigious Neurobiology Conference at Oxford
Date:9/17/2008

Curemark, LLC announced today that Founder and CEO Dr. Joan Fallon has presented Curemark's most recent findings on autism at the Gordon Conference on Neurobiology and Brain Disorders which took place August 24-29 at Magdalene College in Oxford.

Rye, NY (PRWEB) September 17, 2008 -- www.cure-mark.com [Curemark, LLC] announced today that Founder and CEO Dr. Joan Fallon has presented Curemark's most recent findings on autism at the Gordon Conference on Neurobiology and Brain Disorders which took place August 24-29 at Magdalene College in Oxford. This 5-day conference brings together some of the greatest research minds from around the world in the field of neurobiology both from academia and industry.

Dr. Fallon's paper, entitled, "The Role of a Dearth of Amino Acids in the Pathophysiology of Autism" details the groundbreaking discoveries regarding autism and its possible origins. This research is the focus of Curemark's plans for entering into clinical trials.

"It was an incredible honor to be among the most elite scientists in the world looking at the genetics of autism, Alzheimer's, Parkinson's disease and other neurodegenerative conditions." Commented Dr.Fallon, The Gordon Conferences are one of pre-eminent meetings in the world, and I am grateful that Curemark was able to be represented."

Present at the meeting were scientists from MIT, Harvard, Johns Hopkins, Oxford, Cambridge and other prestigious universities from around the world.

Curemark is a drug development company focused on the treatment of neurological and other diseases by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon, which revealed a lack of key enzymes in chil
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. AMA Foundation Presents the Arthur N. Wilson, MD Scholarship to Promising Medical Student From Southeast Alaska
2. USA-ONE Interactive Presents a Free Webinar Series Introducing Docuvation – An Online Document Management Solution
3. AMA Foundation Presents $10,000 Scholarships to Promising Medical Students
4. Neurotherapeutics presents special issue on new treatments for Alzheimers disease
5. Vertos Medical Inc. Presents Clinical Data of its MILD™ Procedure at the 5th Annual Innovative Techniques in Spine Surgery Conference in Los Cabos, Mexico
6. Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary
7. ExonHit Presents Therapeutic and Diagnostic Programs for Alzheimers at ICAD 2008
8. OptiNose presents data on highly effective migraine treatment
9. International Association for Dental Research presents awards and fellowships
10. MIKE AND IKE(R) Lemonade Blends(TM) Presents $100,000 to Alexs Lemonade Stand Foundation
11. Journal STEM CELLS Presents 3rd Annual Young Investigator Award at International Stem Cell Symposium

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... who were treated with cisplatin-based chemotherap...ical side effects and Raynaud-like phenomena, than...ding to a new study published online November 25 i..., Marianne Brydy, M.D., of the Department of Onc...orway, and colleagues conducted a cross-sectional ...
(Date:11/25/2009)...f a collaboration between UCLA engineers and physi...0 million Americans who suffer from peripheral art...the arteries, peripheral arterial disease, or PAD,... arteries reduce blood flow to the limbs. The cond...e, heart attack and stroke, and its progression ca...
(Date:11/25/2009)...o draw definite conclusions, experts say, , ...iabetic patients with blocked coronary arteries, t...e year whether patients undergo bypass surgery or ...ort. , Bypass surgery has been the standard tre...disease. However, less invasive approaches such as...
(Date:11/25/2009)...reatment clinics to resume Monday, Nov. 30 , ... 2009 -- Centegra Health System is continuing to o... four Centegra Primary Care (CPC) vaccination clin... The clinics are at CPC sites in Huntley, Woodstoc...llows: ,   From 4:30 to 7:30 p.m. Tues...
(Date:11/25/2009)...mptoms, study finds , , WEDNESDAY, Nov....are among the potential problems faced by long-ter...with cisplatin-based chemotherapy, a new study has...n treated for unilateral testicular cancer between... conducted from 1998 to 2002. , The researchers...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...lity drugs to get pregnant can breathe a sigh of r...he popular medications used to increase the number...e do not increase the risk of ovarian cancer. // ...ad difficulty conceiving took fertility drugs and ...
...ated that Men who suffer from constipation are mor...in disease Parkinson's some have suggested that th...f the gut long before it manifests itself elsewher...high risk of developing the disease in the future....
...ng under polluted, hazy skies move away to communi...ore quickly, according to a study by researchers a...dicine researchers followed more than 100 children...affected annual rates of lung function growth, the...
...euths found that the absence of a certain protein ... water levels.Reported in the New England journal ...ey works.// The protein aquaporin-1has a d...ency of the protein have a limited ability to reab...
... bagged the registration, production and marketing...he Centre for Biotechnology in the Jawaharlal Nehr...e would be in the market in 3-4 months. The Compan...t to make any projections on the business the vacc...
...covered that frequent sexual intercourse can actua...attack.Middle aged men can have sex as many times/...f having a stroke, according to research. P...between sex and strokes. The team based its findin...
Other Medicine News:Health News:Particulate matter affects lung development 2
(Date:11/25/2009)..., LOVELAND,Colo.,Nov.25/PRNewswire-FirstCall/--He... advanceddiagnosticandspecialtyproductstotheveteri...nosticsCorporationforthesupplyofbloodgasproductsan..., (Logo: http://www.newscom.com/cgi-bin/prnh/20000...ssionforinnovatinginthefieldofadvancedpoint-of-car...
(Date:11/25/2009)..., EXTON,Pa.,Nov.25/PRNewswire/--BioTrendsResearch... Stelara report,thefirstinamulti-phasesyndicatedm...ho-Biotech,sStelara,fromproductlaunchthroughthefir...desquantitativeinformationfrom75uniqueDermatologis...rtsassesstrialanduseofStelara,obstaclestouse,typic...
(Date:11/25/2009)..., BASKINGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBio...tofantithromboticaptamerswithactivecontrolagents,a...resentingatthePiperJaffray21stAnnualHealthCareConf...o,spresentationwillbegivenat1:10pm(EST)onTuesday,D...linewithemphasisontheleaddevelopmentprogram,theant...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Firm Parents Keep Teen Drivers Safe 58357 1Firm Parents Keep Teen Drivers Safe 58357 2Firm Parents Keep Teen Drivers Safe 58357 3Loyola University Chicago awarded scholarships for accelerated nursing students 58354 1Loyola University Chicago awarded scholarships for accelerated nursing students 58354 2M D Anderson scientist wins NIH New Innovator Award 58351 1M D Anderson scientist wins NIH New Innovator Award 58351 2M D Anderson scientist wins NIH New Innovator Award 58351 3
...in treating pediatric acute lymphoblastic,leukemia...ians treat,adolescents and adults with the disease... that has occurred in the cure rate for children w...ficult to replicate in older,patients without cons...cle,by St. Jude Children,s Research Hospital autho...
... NanoBio Corporation,announced today that it has ... its phase 2 study of NB-002, a topical lotion for... remain confidential, the results clearly,justify ...sts., "Allowing adequate time for subjects to gro... infection will enable us to generate data on,comp...
Other Medicine Technology:Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers 2NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis 2
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: